Patrick J. Mahaffy, President and CEO at Clovis Oncology, Inc. (CLVS), bought 50,000 shares at $5.56 ($280K) on 2019-08-16, disclosed to the SEC on 2019-08-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.56 | 400 | $2K | 0.8% |
| 2 | $5.57 | 3,706 | $21K | 7.4% |
| 3 | $5.58 | 11,314 | $63K | 22.6% |
| 4 | $5.58 | 400 | $2K | 0.8% |
| 5 | $5.59 | 3,700 | $21K | 7.4% |
| 6 | $5.59 | 11,053 |
| $62K |
| 22.1% |
| 7 | $5.60 | 5,100 | $29K | 10.2% |
| 8 | $5.60 | 5,827 | $33K | 11.7% |
| 9 | $5.61 | 6,400 | $36K | 12.8% |
| 10 | $5.61 | 2,100 | $12K | 4.2% |
| Total | $5.59 avg | 50,000 | $280K | 100% |
| Filing → |